# OpenClinic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/openclinic

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.openclinic.com/
- Latest round: Seed (Dec 2, 2024)
- Investors on record: 2

## About

OpenClinic provides an AI-powered solution that streamlines the processes of medical history-taking and diagnostic triage. The company is headquartered in San Francisco, US. In January 2025, OpenClinic raised an undisclosed amount of venture funding from CoreNest Capital. The funding will be used to further develop its platform. The founder of OpenClinic has not been disclosed publicly, nor has there been information regarding previous companies founded by them.

OpenClinic offers an AI-driven platform designed to streamline the medical history-taking and diagnostic triaging processes for healthcare providers. The core product facilitates an asynchronous care model where patients interact with an AI voice assistant that conducts comprehensive medical histories through natural conversation. This assistant gathers detailed patient information and employs sophisticated medical reasoning to inform differential diagnoses and treatment suggestions based on the latest medical guidelines. OpenClinic’s target users include medical professionals, specifically doctors and healthcare institutions in the United States and the United Kingdom, among others.

OpenClinic operates on a self-pay model, allowing for straightforward transactions between the company and its clients, which include medical practitioners and healthcare facilities. The revenue structure is centered around the provision of its AI platform, generating revenue through direct payments for services rendered rather than traditional subscription models. Clients access the platform to benefit from enhanced diagnostic tools and treatment suggestions, paying for the AI-driven medical history assessments and associated services based on usage. This transactional nature enables doctors to focus on delivering care while ensuring immediate payment for their expertise.

OpenClinic is focused on further developing its AI platform to improve healthcare delivery. The recent funding from January 2025 will support these development initiatives. The company aims to expand into additional markets beyond the US and the UK, although specific target regions have not been disclosed yet. OpenClinic is actively working on upcoming product features to enhance its offerings, with details about release dates expected to be announced in the near future.

## Funding rounds

- Seed, Dec 2, 2024 — Pioneer Fund, CoreNest

## Investors

- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
- CoreNest — Seed